Arvida Group (ARV) / HY26

PBT swung to -$8.0m loss as fair-value gains evaporated on flat EBITDA

Revenue grew 5% and operating EBITDA held near flat, but the absence of investment property revaluations erased the prior-year profit and lifted...

Release date
28 November 2025
Published
21 April 2026

What changed

Revenue grew 5.1% to $131.9m, driven by deferred management fee growth and higher care and village services income. Operating EBITDA, however, slipped 0.9% to $43.7m — essentially flat — as subdued property market conditions constrained resale margin despite a 4% lift in resale settlement volumes.

The headline swing is stark: PBT moved from a $54.5m profit in HY25 to an $8.0m loss in HY26, a deterioration of $62.5m. The explanation is entirely in the valuation line. HY25 included a $72.9m fair-value gain on investment property; that contribution is absent in HY26. Operating performance itself barely moved.

Operating cash flow fell materially — from $79.5m to $44.7m — a 43.7% decline, while gross borrowings rose 33.9% to $1.03bn from $769m. Net debt widened to approximately $1.02bn, pushing the net debt to operating EBITDA ratio from roughly 17.4x to 23.5x on a half-year annualised basis.

What matters

1. The PBT loss is a valuation accounting story, not an operating deterioration — but operating EBITDA is not growing. The $62.5m PBT collapse is explained by the non-recurrence of the HY25 investment property fair-value gain ($72.9m). Strip that out and the underlying operating result is essentially unchanged year-on-year. The more uncomfortable observation is that operating EBITDA has been flat to slightly negative at the same time revenue is growing 5%, implying margin compression at the operating level. The business is not yet converting revenue growth into earnings growth.

2. Leverage has moved to a level that deserves close attention. Gross borrowings of $1.03bn represent a $260m increase on the prior comparable period. On annualised operating EBITDA of roughly $87m ($43.7m × 2), net debt to EBITDA sits above 11x on an operating basis — a level typical of retirement village operators given their ORA liability structures, but the direction of travel is towards higher, not lower, leverage. The balance sheet grew by $410m in total assets, with total liabilities rising faster (13.9%) than equity (2.0%), narrowing the equity cushion in proportional terms.

3. Cash conversion deteriorated materially. OCF-to-operating EBITDA fell from 180% in HY25 to 102% in HY26. At first pass 102% looks adequate, but the HY25 ratio was inflated by strong resale settlement timing. The $34.8m drop in operating cash flow in a period where EBITDA barely moved suggests working capital, settlement timing, or interest cost movements are absorbing cash that EBITDA does not capture. Without capex disclosure, free cash flow cannot be assessed.

Expectations

No formal guidance or medium-term targets were disclosed, so this assessment is based on the prior-year shape and the internal run-rate.

The prior-year pattern shows EBITDA was second-half weighted: HY25 contributed only 43.7% of full-year FY25 EBITDA of $101m, implying the implied second half (2H25) delivered $56.9m. If a similar seasonal skew applies in FY26, the full-year operating EBITDA outcome depends heavily on second-half execution. HY26's $43.7m would need a second half of approximately $57m+ to match FY25's $101m full-year result — a stretch given current resale market conditions.

Revenue annualised at $263.8m sits about 4% above FY25's $253.7m, suggesting the top line is tracking reasonably. The concern is EBITDA conversion from that revenue growth, which is not yet materialising at the half-year mark.

The NPAT comparison is not a useful forward indicator given its dependence on investment property fair-value movements, which are discretionary in their direction and magnitude.

Quality of result

The operating revenue growth is credible and recurring — care fees, village services, and deferred management fees are contractual or volume-driven in nature. That part of the result has durability.

The flat EBITDA against rising revenue is a durability concern. It implies cost growth is broadly matching revenue growth, with no operating leverage emerging. Whether this reflects labour cost inflation, village development overhead, or the subdued resale market suppressing higher-margin DMF income is not disaggregated in the available disclosures.

The $8.0m PBT loss is entirely a function of the absence of fair-value uplift — a non-cash, mark-to-model item. In that sense, the statutory loss should not be read as operating deterioration. However, if the property market remains subdued, the risk is that future periods also lack this tailwind, and the operating business must carry more of the earnings load on a weaker margin trajectory.

The OCF deterioration is the most tangible quality concern. The 44% drop in operating cash flow, alongside only modest EBITDA change, suggests timing differences in resale settlement receipts or rising cash interest costs are depressing reported cash generation. Given the increase in gross borrowings, higher interest payments are a reasonable inference.

Unresolved

  • The composition of the $260m increase in gross borrowings is not disclosed — whether it is development debt, acquisition-related, or refinancing of existing facilities materially affects the risk profile.
  • Operating EBITDA margin compression is visible but unexplained; the cost drivers are not broken out, making it impossible to assess whether margin pressure is structural or cyclical.
  • No capex or free cash flow figure was provided, so the cash cost of the development pipeline and its drag on distributable cash cannot be assessed.
  • There is no disclosure of ORA resale pricing trends, village occupancy rates across individual segments, or care vs. retirement village EBITDA splits — all of which are material to assessing whether the DMF and resale margin outlook is stabilising or deteriorating.
  • No dividend or distribution was disclosed in the supplied materials, leaving capital return intentions unclear in the context of rising leverage.

This briefing cannot assess the adequacy of covenant headroom on the $1.03bn debt facility or whether the leverage increase breaches or approaches any lender-imposed thresholds.

Key metrics

← Swipe to view more
Metric HY26 HY25 Change
Revenue $131.9m $125.5m +5.1% ↑
EBITDA $43.7m $44.1m -0.9% ↓
Net profit after tax −$8.2m $64.0m -112.8% ↓
Net cash inflow from operating activities $44.7m $79.5m -43.7% ↓
Profit before tax −$8.0m $54.5m -114.7% ↓
Cash and cash equivalents $5.1m $3.9m +32.6% ↑
Total assets $4720.5m $4309.6m +9.5% ↑

Source: annolyse.ai/briefings/arv-hy26

Analytical metrics

← Swipe to view more
Metric HY26 HY25 Context
Effective tax rate n/m (loss period) -17.4% current loss period
OCF / EBITDA (cash conversion) 102.3% 180.3% deteriorated
Debtor days 25.6 29.4 -3.8 days
Trade debtors $18.6m $20.3m −$1.7m
Net debt $1024.6m $765.4m +$259.2m
Net debt / EBITDA 23.45x 17.36x Weakening
Gross borrowings $1029.8m $769.3m +$260.5m
ROE (annualised) -1.0% 8.0% Weakening
HY25 share of FY25 revenue 49.5% Other half was 50.5%
HY25 share of FY25 EBITDA 43.7% Other half was 56.3%
HY25 share of FY25 NPAT 63.5% Other half was 36.5%
Profit from continuing operations −$8.2m $64.0m −$72.2m

Source: annolyse.ai/briefings/arv-hy26


This analysis was generated using Annolyse, an AI-powered tool that extracts and analyses NZX/ASX company announcements. The underlying data is extracted from official company filings and verified against source documents. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Appendix

Source documents

The filings and announcement documents considered in this briefing.

Current period

Prior comparable period

Full-year context

Arvida Group Limited - 2025 Consolidated Financial Statements (Audited)

FY25 / financial report

FY25 Results Announcement (NZX Prescribed Release)

FY25 / results announcement

FY25 Results Market Release

FY25 / results release

Subscribe

Want briefings like this for the next reporting season?

Annolyse is being built as a publication product first. Subscribe for the next release.